Vous avez cherché: gist (Danois - Anglais)

dosering ved gist
posology for gist

alle patienterne havde gist.
all patients had gist.

farmakokinetik hos gist-patienter
pharmacokinetics in gist patients

2% af patienterne med gist.
in clinical trials treatment-related tumour haemorrhage occurred in approximately 2% of patients with gist.

gastrointestinale stromale tumorer (gist)
gastrointestinal stromal tumours (gist)

hvis du er i behandling for gist:
if you are being treated for gist:

gist er en kræftform i mave og tarm.
gist is a cancer of the stomach and bowels.

hovedpine var almindeligst hos gist-patienter.
headache was the most common in gist patients.

behandlingsrelaterede bivirkninger rapporteret i gist-undersøgelserne
treatment-related adverse reactions reported in gist studies

2 hovedpine var mest almindeligt hos gist- patienter.
2 headache was the most common in gist patients.

abdominalsmerter og gastrointestinalblødning blev oftest observeret hos patienter med gist.
6+7 abdominal pain and gastrointestinal haemorrhage were most commonly observed in gist patients.

ikke offentliggjorte data stillet til rådighed af gist-brocades.
unpublished data provided by gist-brocades.

ikke offentliggjort rapport stillet til rådighed af gist-brocades.
unpublished report provided by gist-brocades.

der er ikke rapporteret fatale tilfælde i gist - og mrcc- registreringsstudier.
no cases with fatal outcome were reported in gist and mrcc registrational studies.

ifølge aftalen skulle csk være eneforhandler i nederlandene af gist-brocades osteløbe.
the agreement stipulated that csk became, in the netherlands, the exclusive distributor of rennetproduced by gist-brocades.

ondartede bindevævstumorer i mavetarmsystemet (gastrointestinale stromal tumorer (gist)).
gastrointestinal stromal tumours (gist).

det bør bemærkes, at gist-patienter kan have levermetastaser, hvilket kan medføre leverinsufficiens.
it should be noted that gist patients may have hepatic metastases which could lead to hepatic impairment.

kommissionen godkender dsm n.v.'s overtagelse al' gist brocades pá basis af fusionsforordningen
commission clears the acquisition of gist brocades by dsm n.v. under the merger regulation

der sås hyppigere myelosuppression hos cml-patienter end hos gist-patienter, hvilket sandsynligvis skyldes primærsygdommen.
there was more myelosuppression seen in cml patients than in gist, which is probably due to the underlying disease.

cml i kronisk fase, mds/mpd og gist (startdosis 400 mg) hes/cel (ved 400 mg dosis)
chronic phase cml, mds/mpd and gist (starting dose 400 mg) hes/cel (at dose 400 mg)